Table 1.
Data sets used for classification analysis.
Cancer site | Classes | Samples | Features | Reference |
---|---|---|---|---|
Brain | 2 | 60 (21 censored, 39 failures) | 7,129 | Pomeroy et al[12] |
Prostate | 2 | 102 (52 tumor, 50 normal) | 12,600 | Singh et al[13] |
Breast | 2 | 15 (8 BRCA1, 7 BRCA2) | 3,170 | Hedenfalk et al. [14] |
Breast | 2 | 78 (34 relapse, 44 non-relapse) | 24,481 | van ’t Veer et al[15] |
Colon | 2 | 62 (40 negative, 22 positive) | 2,000 | Alon et al[16] |
Lung | 2 | 32 (16 MPM, 16 ADCA) | 12,533 | Gordon et al[20] |
Leukemia | 2 | 38 (27 ALL, 11 AML) | 7,129 | Golub et al [21] |
Leukemia | 3 | 57 (20 ALL, 17 MLL, 20 AML) | 12,582 | Armstrong et al[22] |
SRBCT | 4 | 63 (23 EWS, 8 BL, 12 NB, 20 RMS) | 2,308 | Khan et al[23] |